MIDDLE EAST PHARMA. & CHMICAL IND. & MEDICAL APPLIANCES Financial
Trading Information in the Regular Market
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Par Value/Share (JD) | 1.00 | 1.00 | 1.00 |
| Closing Price (JD) | 0.00 | 0.00 | 0.00 |
| Value Traded (JD) | 0 | 0 | 0 |
| No. of Shares Traded | 0 | 0 | 0 |
| No. of Transactions | 0 | 0 | 0 |
| No. of Subscribed Shares | 6,250,583 | 6,250,583 | 6,250,583 |
| Market Capitalization (JD) | 0 | 0 | 0 |
| Fiscal Year Ended | 31/12/2021 | 31/12/2020 | 31/12/2019 |
Assets (JD)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Cash on Hand & at Banks | 43,323 | 104,350 | 174 |
| Accounts Receivable, Net | 621,621 | 1,150,480 | 1,364,450 |
| Notes Receivable | 0 | 0 | 0 |
| Post Dated Cheques | 670,087 | 460,546 | 946,390 |
| Short Term Investments | 0 | 0 | 14,114 |
| Inventory | 1,630,859 | 1,949,786 | 2,219,632 |
| Spare Parts | 189,822 | 203,193 | 215,167 |
| Total Current Assets | 3,996,341 | 4,171,099 | 5,089,153 |
| Long Term Investments | 0 | 0 | 0 |
| Fixed Assets, Net | 5,577,805 | 5,894,711 | 6,484,411 |
| Lands | 200,606 | 200,606 | 200,606 |
| Projects in Progress | 0 | 0 | 0 |
| Total Fixed Assets | 5,778,411 | 6,095,317 | 6,685,017 |
| Other Assets | 104,258 | 110,837 | 150,105 |
| Total Assets | 9,879,010 | 10,377,253 | 11,924,275 |
Liabilities (JD)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Accounts and Notes Payable | 6,059,191 | 7,088,782 | 7,381,090 |
| Credit Banks | 0 | 0 | 0 |
| Short Term Loans | 0 | 201,919 | 654,158 |
| Current Part of Long Term Loans | 0 | 0 | 0 |
| Total Current Liabilities | 8,559,413 | 9,586,713 | 10,419,017 |
| Long Term Loans & Notes Payable | 229,097 | 0 | 0 |
| Corporate Bonds | 0 | 0 | 0 |
| Other Liabilities | 8,709,783 | 8,529,829 | 7,967,579 |
| Total Liabilities | 17,498,293 | 18,116,542 | 18,386,596 |
Income Statement (JD)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Operating Revenues | 5,073,896 | 2,915,186 | 4,044,239 |
| Operating Expenses | 3,922,141 | 2,742,745 | 3,072,119 |
| Gross Profit | 1,151,755 | 172,441 | 972,120 |
| General and Administrative Expenses | 834,842 | 579,577 | 616,359 |
| Selling and Distribution Expenses | 419,049 | 457,565 | 783,971 |
| Depreciation (Period) | 628,687 | 650,225 | 690,645 |
| Other Operating Expenses | 283,164 | 180,867 | 188,467 |
| Net Operating Income | -385,300 | -1,045,568 | -616,677 |
| Other Revenues | 520,642 | 0 | 116,865 |
| Other Expenses | 0 | 257,332 | 0 |
| Income Before Interest & Tax | 135,342 | -1,302,900 | -499,812 |
| Interest Expenses | 0 | 0 | 0 |
| Net Income Before Tax | 135,342 | -1,302,900 | -499,812 |
| Income Tax (Period) | 0 | 0 | 0 |
| Income Tax (Previous Years) | 0 | 0 | 0 |
| Universities and Research Train Fees | 0 | 0 | 0 |
| Board of Directors Remuniration | 0 | 0 | 0 |
| Net Income | 135,342 | -1,302,900 | -499,812 |
| Non-controlling Interest | 0 | 0 | 0 |
| Net Income Pertains to Shareholders | 135,342 | -1,302,900 | -499,812 |
Cash Flow (JD)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Cash Balance (Beginning) | 104,350 | 174 | 12,320 |
| Net Cash Flow from (Used in) Operating Activities | 1,077,497 | 5,029 | -50,047 |
| Net Cash Flow from (Used in) Investing Activities | -333,974 | -30,478 | -27,779 |
| Net Cash Flow from (Used in) Financing Activities | -804,550 | 129,625 | 65,680 |
| Cash Balance (Ending) | 43,323 | 104,350 | 174 |
Financial Ratios
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Turnover Ratio % | 0.000 | 0.000 | 0.000 |
| Earning Per Share (JD) | 0.022 | -0.208 | -0.080 |
| Dividend Per Share (JD) | 0.000 | 0.000 | 0.000 |
| Book Value Per Share (JD) | -1.219 | -1.238 | -1.034 |
| Price Earnings Ratio (Times) | 0.000 | 0.000 | 0.000 |
| Dividend Yield % | 0.000 | 0.000 | 0.000 |
| Dividend Per Share to Earning Per Share % | 0.000 | 0.000 | 0.000 |
| Price to Book Value (Times) | 0.000 | 0.000 | 0.000 |
| Gross Margin % | 22.700 | 5.915 | 24.037 |
| Margin Before Interest and Tax % | 2.667 | -44.694 | -12.359 |
| Profit Margin % | 2.667 | -44.694 | -12.359 |
| Return On Assets % | 1.370 | -12.555 | -4.192 |
| Return On Equity % | -1.776 | 16.835 | 7.734 |
| Debt Ratio % | 177.126 | 174.579 | 154.195 |
| Equity Ratio % | -77.126 | -74.579 | -54.195 |
| Interest Coverage Ratio (Times) | 0.000 | 0.000 | 0.000 |
| Total Assets Turnover (Times) | 0.514 | 0.281 | 0.339 |
| Fixed Assets Turnover (Times) | 0.878 | 0.478 | 0.605 |
| Working Capital Turnover (Times) | -1.112 | -0.538 | -0.759 |
| Current Ratio (Times) | 0.467 | 0.435 | 0.488 |
| Working Capital (JD) | -4,563,072.000 | -5,415,614.000 | -5,329,864.000 |